Correlation Between Stryker and Lifeline Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Stryker and Lifeline Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stryker and Lifeline Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Stryker and Lifeline Biotechnologies, you can compare the effects of market volatilities on Stryker and Lifeline Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stryker with a short position of Lifeline Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stryker and Lifeline Biotechnologies.

Diversification Opportunities for Stryker and Lifeline Biotechnologies

-0.45

Correlation Coefficient

Stryker  Lifeline Biotechnologies

Very good diversification

The 3 months correlation between Stryker and Lifeline is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Stryker and Lifeline Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lifeline Biotechnologies and Stryker is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stryker are associated (or correlated) with Lifeline Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lifeline Biotechnologies has no effect on the direction of Stryker i.e., Stryker and Lifeline Biotechnologies go up and down completely randomly.

Pair Corralation between Stryker and Lifeline Biotechnologies

Considering the 90-day investment horizon Stryker is expected to under-perform the Lifeline Biotechnologies. But the stock apears to be less risky and, when comparing its historical volatility, Stryker is 87.17 times less risky than Lifeline Biotechnologies. The stock trades about -0.23 of its potential returns per unit of risk. The Lifeline Biotechnologies is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Lifeline Biotechnologies on September 24, 2024 and sell it today you would earn a total of  0.00  from holding Lifeline Biotechnologies or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.24%
Values	Daily Returns

Stryker  vs.  Lifeline Biotechnologies

Stryker

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Stryker are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Stryker is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Lifeline Biotechnologies

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Lifeline Biotechnologies are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental drivers, Lifeline Biotechnologies displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Stryker and Lifeline Biotechnologies

The main advantage of trading using opposite Stryker and Lifeline Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stryker position performs unexpectedly, Lifeline Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifeline Biotechnologies will offset losses from the drop in Lifeline Biotechnologies' long position.

The idea behind Stryker and Lifeline Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.